Thailand Anti Aging Therapeutics Market Report 2022 to 2030

Thailand Anti Aging Therapeutics Market Analysis

$ 3999

Thailand's anti-ageing therapeutics market is expected to witness growth from $1 Mn in 2022 to $3 Mn in 2030 with a CAGR of 16,87% for the year 2022-2030. As Thailand is one of the most popular destinations for medical tourism in anti-ageing treatments, the market in Thailand has enormous potential and is projected to grow during the forecast period. The Thailand anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Tulip Group, Algaeba, and Bo International are some of the leading companies in the market.

ID: IN10THPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: Thailand AUTHOR: Parul Choudhary

Buy Now

Thailand Anti-Aging Therapeutics Market Executive Summary

Thailand's anti-ageing therapeutics market size is at around $1 Mn in 2022 and is projected to reach $3 Mn in 2030, exhibiting a CAGR of 16.87% during the forecast period. The Universal Coverage Scheme will receive $5.96 Bn in the fiscal year 2023, an increase of 4.12% from the prior year, as authorized by the Thai cabinet. The recently introduced services are mostly associated with COVID-19, including costs for RT-PCR tests, antigen test kits (ATKs), and services for COVID vaccination. Upgrades to the universal healthcare system's services, a telemedicine program, and the promotion of medicinal cannabis are all planned to be covered by the budget for the 2023 fiscal year. Furthermore, it allocates funds for the Government Pharmaceutical Organization to buy immunizations, medications, and medical equipment. The proposed budget would give $4.14 Bn to the National Health Security Fund and $1.76 Bn to cover salary expenses. The allocation for the universal healthcare program will include funding for services for people who are bedridden, HIV and AIDS treatment, chronic disease prevention and treatment, chronic renal failure, and other conditions.

Estrogen replacement therapy (ERT) is the single largest active anti-ageing study. It was first used forty years ago to treat hot flashes and other menopausal complaints in Thailand. But four decades of therapy have demonstrated that it significantly lowers cardiovascular disease and stroke-related deaths by 50%. Estrogen protects against osteoporosis, reduces the chance of Alzheimer's, Parkinson's, and diabetes, firms and smoothes the skin, improves memory, and energizes women.

Chula Medicine in Thailand has created RED-GEMs (REjuvenating DNA by GEnomic Stability Molecules), which effectively slow down the aging process in laboratory animals. The medical innovation aims to cure a variety of age-related conditions and illnesses and restore youth in this aging society, with human trials scheduled within two years. The primary answer to health issues in an aging society and a source of revenue for Thailand is the ability of RED-GEMs to reverse aging. Increased DNA gaps, the removal of DNA lesions, and cell senescence can all be improved by RED-GEMs.

Thailand Anti Aging Therapeutics Market

Market Dynamics

Market Growth Drivers Analysis

Many people visit Thailand for cosmetic procedures, such as anti-aging treatments, making it one of the top destinations for medical tourism. This is boosting the Thailand anti-aging therapeutics market. Thais are increasingly looking for methods to maintain their health and ward off age-related illnesses as they become more health conscious. The demand for anti-aging therapeutics and associated goods is being driven by this. The National Health Security Act and the Thailand 4.0 initiative are two of the government of Thailand's recent efforts to support healthy aging. These efforts will probably open doors for anti-aging businesses and stimulate the Thailand anti-aging therapeutics market expansion.

Market Restraints

Anti-aging treatments and therapies can be costly, limiting their accessibility to people with reduced incomes. This might slow the Thailand anti-aging therapeutics market expansion, especially among lower-income groups. Thai traditional medicine, which includes herbal remedies and complementary therapies, has a long record, which might reduce the demand for anti-aging medications among people who would rather use these treatments. The lack of access to healthcare in Thailand, despite the nation's reputation as a centre for medical tourism, may reduce demand for anti-aging therapeutics among some populations.

Competitive Landscape

Key Players

StemCells21 (THA)
IncreBio (THA)
Demarest Clinic (THA)
Tulip Group (THA)
Algaeba (THA)
Bo International
Candela Corporation
Merz Pharma
Cutera
Hologic
IRIDEX Corporation
DEKA Medical

Healthcare Policies and Regulatory Landscape

The Food and Drug Administration (FDA) is Thailand's regulatory authority in charge of regulating the use and distribution of anti-aging medications. The FDA is in charge of ensuring the safety, effectiveness, and quality of pharmaceuticals in Thailand, including anti-aging medications. It controls the marketing, distribution, and registration of pharmaceuticals, including anti-aging medications, and it keeps track of their use to ensure their effectiveness and safety. The National Health Security Office (NHSO), which was created by the Thai government in addition to the FDA, is in charge of providing health insurance to Thai citizens. The NHSO has a part to play in regulating healthcare expenses and making sure that anti-aging treatments are both affordable and available to the Thai people. In order to ensure the safety, effectiveness, and accessibility of anti-aging medications in Thailand, the Food and Drug Administration (FDA) and the National Health Security Office (NHSO) both play significant parts in the regulation of their use and distribution.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

Anti-Wrinkle
Hair Color
Ultraviolet (UV) Absorption
Anti-Stretch Mark
Others

By Treatment (Revenue, USD Billion):

Hair Restoration
Anti-Pigmentation
Adult Acne Therapy
Breast Augmentation
Liposuction
Chemical Peel
Others

By Target Group (Revenue, USD Billion):

Male
Female

By Type of Aging (Revenue, USD Billion):

Cellular Aging
Immune Aging
Metabolic Aging
Others

By Type of Molecules (Revenue, USD Billion):

Biologics
Small Molecules

By Mechanism of Action (Revenue, USD Billion):

Senolytic
Cell Regeneration
mTOR inhibitor/Modulator
AMP-kinase/AMP Activator
Mitochondria Inhibitor/Modulator
Others

By Ingredient (Revenue, USD Billion):

Retinoid
Hyaluronic Acid
Alpha Hydroxy Acid
Others

By Distribution Channel (Revenue, USD Billion):

Pharmacies
Stores
Online Stores

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.